Discover more insights into Somatostatin Analogues ソマトスタチン類似体

Keywords frequently search together with Somatostatin Analogues ソマトスタチン類似体

Narrow sentence examples with built-in keyword filters

Somatostatin Analogues sentence examples within peptide receptor radionuclide



Phase I study of autolytic immunotherapy of metastatic neuroendocrine tumors using intralesional rose bengal disodium.


Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment

Somatostatin Analogues sentence examples within positron emission tomography



Is SUVmax a useful marker for progression-free survival in patients with metastatic GEP-NET receiving 177Lu-DOTATATE therapy?


Use of full-dose contrast-enhanced CT for extrahepatic staging using Gallium-68-DOTATATE PET/CT in patients with neuroendocrine tumors.

Somatostatin Analogues sentence examples within progression free survival



Target therapies plus somatostatin analogues in NETs: a network meta-analysis.


The Landmark Series: Management of Small Bowel Neuroendocrine Tumors



Somatostatin Analogues sentence examples within Acting Somatostatin Analogues



TSH and GH Producing Macroadenoma. Escape to Control with Long-Acting Somatostatin Analogues (SSA) After 12 Years Follow-Up. About A Case


Clinical Presentation and Management of Patients With Acromegaly at a University Hospital

Somatostatin Analogues sentence examples within Generation Somatostatin Analogues



Cost-Utility of Acromegaly Pharmacological Treatments in a French Context


Resistance to drug treatment of acromegaly and ways to overcome it

Somatostatin Analogues sentence examples within Radiolabelled Somatostatin Analogues



Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours


Long-term survival and toxicity in patients with progressive advanced neuroendocrine tumors treated with lutetium peptide radiolabelled radiotherapy: A Western Australian long-term follow-up study.

Somatostatin Analogues sentence examples within Radiolabeled Somatostatin Analogues



Incidental Finding of Squamous Cell Carcinoma on a 68Ga-DOTATATE PET Scan


Evaluation of SSTR2 Expression in SI-NETs and Relation to Overall Survival after PRRT

Somatostatin Analogues sentence examples within Labeled Somatostatin Analogues



Use of full-dose contrast-enhanced CT for extrahepatic staging using Gallium-68-DOTATATE PET/CT in patients with neuroendocrine tumors.


Dual tracer hybrid radionuclide imaging of a metastatic gastrointestinal neuroendocrine tumor with unknown primary site using 18F-FDG PET/CT and 99mTc-HYNIC-TOC SPECT/CT (case report and literature review)

Somatostatin Analogues sentence examples within somatostatin analogues may



Metastatic Pheochromocytomas and Abdominal Paragangliomas


Octreotide use for rescue of vision in a pregnant patient with acromegaly

Somatostatin Analogues sentence examples within somatostatin analogues might



Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro.


Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.


Management of Chyle Leak After Head and Neck Surgery; Our Meritorious Experience in 52 Cases and Review of Literature



Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?



Nuclear Medicine Imaging Procedures in Oncology.



Treatment of human intestinal cryptosporidiosis: A review of published clinical trials



PET findings after COVID-19 vaccination: “Keep Calm and Carry On”



Severe hyperglycemia following transition from octreotide to lanreotide in a patient with enterocutaneous fistula receiving parenteral nutrition.



An aggressive poorly differentiated plurihormonal Pit-1-positive adenoma.



Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results‐Medicare analysis of 5235 patients



Update on Incidence, Prevalence, Treatment and Survival of Patients with Small Bowel Neuroendocrine Neoplasms in the Netherlands



Combination Therapies with PRRT



Upper Gastrointestinal Bleeding.



Chylous ascites in colorectal surgery: A systematic review



A phase I study of safety and immunogenicity of survivin long peptide vaccine (SurVaxM) in patients (pts) with metastatic neuroendocrine tumors (NETs).



Treatments and ongoing monitoring for patients with neuroendocrine tumors, monitored by medical oncologists: Scan comparative data between advanced economies (AE) and emerging and developing economies (EDE).



Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg)



Value of a patient-reported-outcome measure of carcinoid syndrome symptoms.



Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion



Invited Commentary: Evaluating Nationwide Application of Minimally Invasive Surgery for Treatment of Small Bowel Neuroendocrine Neoplasms



Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients



Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis



Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience



Successful Pregnancies in an Acromegalic Woman After Non-Radical Pituitary Adenomectomy for Somatoprolactinoma



Peptide receptor radionuclide therapy for GEP-NET: consolidated knowledge and innovative applications



Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot



Telotristat in the management of Carcinoid diarrhoea – A real world experience of patients from ENETs centre of excellence in Neuroendocrine tumours



Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series.



Gastric neuroendocrine neoplasms: A review



Skin anomalies in acromegalic patients (Review of the practical aspects).



Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.



Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging



Neuroendocrine neoplasia and bone (Review).



Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience



Treatment outcomes of advanced digestive well-differentiated grade 3 NETs.



NETs of the Lung



USEFULNESS OF BIODEGRADABLE STENT IN THE PREVENTION OF PANCREATIC FISTULA AFTER PANCREATIC SURGERY



[Clinical Course of Typical and Atypical Carcinoids (bpNET): Evaluation of PneuNET Register Berlin Data for the Identification of Indicators for Prognosis Determination and Therapy Planning].



D. Taïeb and K. Pacak (Eds). Current Diagnostic and Therapeutic Approaches in Nuclear Endocrinology



Efficacy and safety of 177Lu-DOTATATE in patients (pts) with advanced pancreatic neuroendocrine tumors (pNETs): Data from the NETTER-R international, retrospective registry.



Management of Late Dumping Syndrome Induced Hypoglycemia With GLP-1R Agonist



Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study



Successful management of severe gastrointestinal bleeding from jejunal angiodysplasia in a patient with Bernard-Soulier syndrome



Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells.



A Rare Case of Thyrotropin Secreting Pituitary Macroadenoma Primarily Treated With Somatostatin Analogue



Current Paradigm of Treatment for Pancreatic Neuroendocrine Tumor



Application of molecular probes in nuclear imaging of neuroendocrine tumors.



Quantitative digital image analysis of somatostatin receptor 2 immunohistochemistry in pancreatic neuroendocrine tumors